Sun Pharma launches solution for dry eye treatment with NCELL™ technology in Canada

Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies), today announced the launch of CEQUA, a new treatment for Canadians living with dry eye disease. CEQUA (cyclosporine ophthalmic solution 0.09% w/v), a calcineurin inhibitor immunomodulator, is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration.

"We are excited to introduce CEQUA as a new treatment option for the more than six million Canadians living with dry eye disease1," said Abhay Gandhi, CEO North America, Sun Pharma. "This launch is an important milestone for Sun Pharma as we expand our ophthalmics portfolio into Canada and it demonstrates our commitment to providing innovative medicines to support patient and physician choice."

In addition to its previous prevalence amongst Canadians, a recent report from Centre for Ocular Research & Education (CORE) has shown that rates of dry eye disease are on the rise due to an increase in mask wearing, which can lead to dry spots on the ocular surface.

"We are delighted to see a new product now available to the many Canadians suffering from keratoconjunctivitis sicca or dry eye disease," said W. Bruce Jackson, MD, former Professor and Chair, Department of Ophthalmology, McGill University and University of Ottawa. "CEQUA, with its nanomicellar technology and increased strength of cyclosporine, can be an important addition to our treatment options as eye care professionals strive for more personalized treatment."

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 807.00 as compared to the previous close of Rs. 799.90. The total number of shares traded during the day was 325385 in over 5973 trades.

The stock hit an intraday high of Rs. 811.35 and intraday low of 785.00. The net turnover during the day was Rs. 260881088.00.

™ - All brand names and trademarks are the property of their respective owners

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 DryEyeTreatment NCELLTechnology CEQUA